Idifarma provides contract development and manufacturing services for niche and highly potent generic or innovative drugs

Pharmaceutical R&D and Manufacturing Services

Idifarma is an independent, privately-owned pharmaceutical CDMO based in Spain and specializing in highly potent drugs.

With an experienced staff of 100+ people and over 100 international clients, Idifarma provides a full range of services covering most of the lifecycle of any pharmaceutical product from first pre-formulation trials to commercial manufacturing: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, stability studies, regulatory affairs, GMP contract manufacturing and packaging for clinical or commercial use.

Its state-of-the-art facility features a purpose-built high containment plant for GMP manufacturing of oral solid dosage forms, for both highly potent and non-potent drugs.

Idifarma’s expertise, capabilities and proven track record make it the perfect partner for the development of your projects.



Idifarma participated in Bio-Europe 2018 last week with very positive results. Thank you very much for your time and interest!

¿Que competencias son necesarias para encontrar un puesto de trabajo? Sesión sobre entrevista de trabajo en la #careerweekunav impartida por Muskilda Pascualena, Directora de RRHH de @Idifarma #farmaciaunav

Next week we will be present at #BIOEurope in Copenhagen, 5th to 7th November.
Do you want to know more about our services? Let's contact us at !

The Spanish contract development and manufacturing organisation @Idifarma has begun its seventh project with the biotechnology company, Palobiofarma |

Idifarma strengthens Palobiofarma relationship with seventh project. Do you want to know more? Read all the information here,

Load More...

Do you want to receive the latest news from Idifarma?

Utilizamos cookies propias y de terceros para realizar el análisis de la navegación de los usuarios y mejorar nuestros servicios. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración pulse aquí ACEPTAR

Aviso de cookies